CL$78.865
Chart
Performance
Key Stats
AI CL Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyColgate-Palmolive exhibits strong fundamental characteristics with a stable business model and consistent dividend payouts. Thematic alignment is moderate, while technical indicators suggest a consolidation phase after recent price action. Suitable for investors seeking stability and income.
Thematic
Colgate-Palmolive is a well-established consumer staples company. Its thematic alignment is primarily driven by consumer spending trends and the growing importance of health and hygiene. Innovation in eco-friendly products and expansion in emerging markets offer moderate growth potential.
Fundamental
Colgate-Palmolive demonstrates strong financial health with robust profitability, healthy cash flow generation, and a manageable debt level. Its consistent dividend growth and share repurchase programs are attractive for income-seeking investors.
Technical
The stock is trading within a recent range, showing mixed signals across different timeframes. While the long-term trend remains somewhat stable, short-term momentum indicators suggest a period of consolidation or a potential minor pullback.
| Factor | Score |
|---|---|
| Consumer Staples Demand | 80 |
| Health & Hygiene Trends | 70 |
| Emerging Market Growth | 75 |
| ESG & Sustainability | 60 |
| Digital Transformation | 55 |
| Factor | Score |
|---|---|
| Valuation | 70 |
| Profitability | 85 |
| Growth | 40 |
| Balance Sheet Health | 90 |
| Cash Flow | 95 |
| Dividends | 80 |
| Factor | Score |
|---|---|
| Trend Analysis | 40 |
| Momentum | 50 |
| Volume Confirmation | 60 |
| Support & Resistance | 55 |
| Short-term Oscillators | 50 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Consistent EPS Surprises
Colgate-Palmolive (CL) has exceeded earnings per share (EPS) estimates in each of the last twelve quarters, with an average surprise of 3.83%. This demonstrates consistent operational execution and effective management.
Reasonable P/E Ratio Relative to Peers
The trailing P/E ratio of 25.06 is within a reasonable range compared to its historical averages and industry peers, suggesting the stock is not excessively overvalued given its market position.
Bearish Points (7)
Increasing P/E Ratio Over Time
The trailing P/E ratio has generally trended upwards from 25.06 to 33.1 (TTM), which, without commensurate earnings growth, could signal that the stock is becoming expensive relative to its earnings.
Slowing Revenue Growth
While revenue for 2024 ($20.10 billion) is higher than 2023 ($19.46 billion), the year-over-year growth rate appears to be slowing, which could indicate market saturation or increased competition.
Calendar
July 2025
18
Ex-Dividend Date
August 2025
1
Next Earnings Date
H: $0.94
A: $0.90
L: $0.85
H: 5.08B
A: 5.04B
L: 4.99B
August 2025
15
Next Dividend Date
Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Seasonals
Price Target
98.01 USD
The 39 analysts offering 1 year price forecasts for CL have a max estimate of 108.00 and a min estimate of 84.18.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 100
Direct and primary global competitor across multiple consumer product categories including oral care (Crest, Oral-B), personal care (Gillette, Old Spice), and home care (Tide, Dawn).
Weight: 98
Major global competitor with a vast portfolio spanning personal care (Dove, Axe), home care (Sunlight, Cif), and food, directly competing in various segments.
Weight: 95
The consumer health spin-off of Johnson & Johnson, directly competes in oral care (Listerine) and other personal and over-the-counter health products.
Weight: 93
Significant competitor in household cleaning (Lysol, Air Wick) and health products (Dettol), overlapping with Colgate's home care and personal care segments.